FAQ
In silico experimentation is a model-based approach that uses mathematical representations to simulate and analyze physical systems in a virtual environment. It enables the prediction of how products, processes, or phenomena will behave under various conditions, generating technical and scientific evidence to support decisions related to design, performance, and safety — especially in the early stages of development.
Yes. Computational simulation makes it possible to generate quantitative and qualitative evidence of a technology's performance during development, even before a physical prototype is available. This information helps demonstrate the product’s potential to investors, highlighting its benefits and unique value.
It can also be used as supporting evidence for regulatory bodies, especially when aiming to demonstrate safety, efficacy, or regulatory compliance.
TESTIMONIALS
We have been thrilled with the outstanding work from the team at INSILICO STEM. Their talent and skill provides advanced methods to vastly improve R&D efforts and regulatory processes that help accelerate progress tremendously.
Erik Kulstand, MD, MS
Co-founder & CMO
Board Member
OUR CLIENTS
Investment attraction
Show project feasibility at early stages, before committing to physical prototypes.
.png)
Regulatory compliance
Provide technical evidence to support regulatory evaluation and approval.
Faster access to market
Quickly evaluate technologies in the pre-market stage to accelerate development.
.png)
Generate scientific evidence
Produce data that supports publications, patents, and design decisions.
OUR SERVICES
Simulation products—available and in development—custom COMSOL consulting, and scientific output. Driven by research, aligned with industry.
InnovaSim
Tailored simulation solutions designed to meet specific
needs.
COMSOL Expert
Live sessions to help you move your COMSOL models forward successfully.
SciPRO
Scientific publications and event participation driven by our collaboration.
AREAS OF EXPERIENCE
At In Silico STEM, we conduct in silico device testing and in silico clinical trials of ablation devices and techniques such as RFA, PFA, laser, cryoablation, among others. These simulations make it possible to analyze the progression of tissue damage. Based on this information, treatment protocols can be optimized, safety thresholds evaluated, and risk factors identified — all contributing to the development of safer and more effective therapies.the text to include your own content. Adjust the font, size or scale to customize the style.
CONTACT US
Calle 52 81-48, 050035
Medellín, Colombia
Marcela Mercado Montoya
CEO, CMO
Phone: +57 315-480-11-00